SeaStar Medical Holding Corporation has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated August 23, 2024. The company, headquartered in Denver, Colorado, seeks to have the Registration Statement become effective at 4:30 p.m. Eastern Time on August 27, 2024, or as soon as possible thereafter. SeaStar Medical's CEO, Eric Schlorff, signed the request, indicating the company's readiness to proceed with the registration process. The SEC has been asked to confirm the effectiveness of the Registration Statement orally with SeaStar Medical's counsel, Dorsey & Whitney LLP, following its declaration.

SeaStar Medical Holding Corporation has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated August 23, 2024. The company, headquartered in Denver, Colorado, seeks to have the Registration Statement become effective at 4:30 p.m. Eastern Time on August 27, 2024, or as soon as possible thereafter. SeaStar Medical's CEO, Eric Schlorff, signed the request, indicating the company's readiness to proceed with the registration process. The SEC has been asked to confirm the effectiveness of the Registration Statement orally with SeaStar Medical's counsel, Dorsey & Whitney LLP, following its declaration.